Socio-cultural determinants of anticipated acceptance of an oral cholera vaccine in western Kenya (Publications)
s. Nearly all (99%) residents indicated willingness to accept a no-cost OCV, 95% at a price of US$ 0.8, 73% at US$ 4.2 and 59% at US$ 8.4. Logistic regression models analysed socio-cultural determinants
Travellers' profile, travel patterns and vaccine practices - a 10-year prospective study in a Swiss Travel Clinic (Publications)
client-trips were recorded. Fifty-one percent clients were female. Mean age was 32 years. In total, 0.1% were aged /=80 years. Forty-six percent of travellers had pre-existing medical conditions. Forty-six
<em>Ascaris lumbricoides</em> egg die-off in an experimental excreta storage system and public health implication in Vietnam (Publications)
Romanenko method, which identified and counted live and dead eggs. RESULTS: From the first sampling (0 storage day) to the final sampling (181 storage days) the average percentage of viable A. lumbricoides
Sensitive and accurate quantification of human malaria parasites using droplet digital PCR (ddPCR) (Publications)
falciparum, and equal sensitivity for P. vivax. Correspondence in quantification was very high (> 0.95) between qPCR and ddPCR. Quantification between technical replicates by ddPCR differed 1.5-1.7-fold
Pharmacokinetics, tolerability, and bacteriological response of rifampin administered at 600, 900, and 1,200 milligrams daily in patients with... (Publications)
assessed by culture conversion in liquid and solid media.Results. Geometric mean total exposures (AUC0-24h) were 24.6, 50.8 and 76.1 h*mg/L in the 600 mg, 900 mg and 1200 mg group respectively, reflecting
Predictors of residual antimalarial drugs in the blood in community surveys in Tanzania (Publications)
having LF/DLF or SP in the blood. RESULTS: Amongst 6391 participants, 12.4% (792/6391) had LF/DLF and 8.0% (510/6391) SP in the blood. Factors associated with higher odds of detecting LF/DLF in the blood included
Safety profile of the meningococcal conjugate vaccine (Menafrivac™) in clinical trials and vaccination campaigns: a review of published studies (Publications)
included with an overall local AEFI I of 11,496/100,000 doses administered per week in clinical trials and 0.72/100,000 doses in immunization campaigns. An Id of 11,497.92 [11,497.91-11,497.93] and 17,243.20 [17
Neglected tropical diseases in the People's Republic of China: progress towards elimination (Publications)
tted helminth infection, clonorchiasis, taeniasis, and echinococcosis in 2015 were 29.1 million, 6.0 million, 366 200, and 166 100, respectively. In 2017, after more than 60 years of uninterrupted, mu
Estrogen-progestin replacement therapy and endometrial cancer (Publications)
10 days), there was essentially no increased risk (adjusted OR = 1.07 per 5 years of use; 95% CI = 0.82-1.41) (79 case subjects and 88 control subjects). Continuous combined replacement therapy was also [...] also associated with essentially no increased risk (adjusted OR = 1.07 per 5 years of use; 95% CI = 0.80-1.43) (94 case subjects and 81 control subjects). CONCLUSIONS: The progestin in sequential estrog
Effectiveness of Active-Online, an Individually Tailored Physical Activity Intervention, in a Real-Life Setting: Randomized Controlled Trial (Publications)
moderate- and vigorous-intensity activity from baseline to FU1 (coefficient = 0.14, P = .001) and to FU3 (coefficient = 0.19, P < .001) in all participants with no significant differences between groups
